Blood and tissue markers to detect lung cancer early
Part of Cancer, Lungs & breathing clinical trials.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 85 years old.
- You have been diagnosed with lung cancer that can be removed by surgery, and you haven't started treatment for it yet.
- You have never been treated for lung cancer or any other cancer before.
- You have not had chemotherapy, radiation, or other treatments before surgery for this cancer.
- You are not pregnant.
- You are able to understand the study and give your permission to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study looks for new “epigenetic” signals in blood (signals about how genes are turned on/off) to help detect lung cancer early. You might be able to join if you are being evaluated for possible lung cancer or have small, unclear spots on a lung CT scan.
This study is testing a new way to help find lung cancer earlier by combining imaging (like CT scans) with a blood test that looks at DNA changes. If you have lung cancer and haven't started treatment yet, participating may help improve future detection methods.
This study is testing a new blood test that looks for changes in DNA to detect lung cancer early. It's for people with a new lung cancer diagnosis, those with uncertain CT scan results, healthy volunteers, or those with chronic lung problems.
This study uses a special blood test to look for tiny traces of lung cancer after surgery. It aims to find “minimal residual disease,” meaning cancer cells that may still be hiding after your tumor is removed.
This study checks whether a special blood test (ctDNA) taken before and after surgery can predict whether non-small cell lung cancer will come back. If it works, it may help doctors spot recurrence earlier and guide follow-up care after tumor removal.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.